• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,2-二氯-1,1,1-三氟乙烷(HCFC-123)的气体摄取药代动力学

Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).

作者信息

Loizou G D, Urban G, Dekant W, Anders M W

机构信息

Department of Pharmacology, University of Rochester, NY 14642.

出版信息

Drug Metab Dispos. 1994 Jul-Aug;22(4):511-7.

PMID:7956723
Abstract

The in vivo metabolic rate constants for the metabolism of the chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123) were determined for both male and female rats with a physiologically based pharmacokinetic model. Uptake studies with 500-5,000 ppm HCFC-123 indicated that a single saturable component was involved in both sexes, and no significant differences were observed in in vivo metabolic rate constants between male and female rats. The in vivo metabolic rate constants obtained from computer simulation studies were: for male rats--KM = 1.2 mg liter-1 (7.85 mumol liter-1) and Vmaxc = 7.20 +/- 0.28 mg kg-1 hr-1 (47.1 +/- 1.83 mumol kg-1 hr-1); for female rats--KM = 1.2 mg liter-1 (7.85 mumol liter-1) and Vmaxc = 7.97 +/- 0.30 mg kg-1 hr-1 (52.1 +/- 1.96 mumol kg-1 hr-1). The physiologically based pharmacokinetic model failed to simulate the reduction in HCFC-123 uptake in female rats at 2,000-5,000 ppm. The production and excretion of trifluoroacetic acid, the major urinary metabolite of HCFC-123, was also predicted by the physiologically based pharmacokinetic model with in vivo metabolic rate constants obtained in the gas-uptake simulation studies. Diallyl sulfide, a selective, mechanism-based inhibitor of cytochrome P450 2E1, inhibited the metabolism of HCFC-123, as indicated by a decreased uptake of HCFC-123 and by a lowered urinary excretion of trifluoroacetic acid in diallyl sulfide-treated rats.

摘要

利用基于生理学的药代动力学模型,测定了雄性和雌性大鼠体内氯氟烃替代物2,2 - 二氯 - 1,1,1 - 三氟乙烷(HCFC - 123)代谢的代谢速率常数。对500 - 5000 ppm HCFC - 123的摄取研究表明,两性均涉及单一的可饱和成分,并且雄性和雌性大鼠体内的代谢速率常数未观察到显著差异。通过计算机模拟研究获得的体内代谢速率常数为:雄性大鼠——KM = 1.2毫克/升(7.85微摩尔/升),Vmaxc = 7.20±0.28毫克/千克·小时-1(47.1±1.83微摩尔/千克·小时-1);雌性大鼠——KM = 1.2毫克/升(7.85微摩尔/升),Vmaxc = 7.97±0.30毫克/千克·小时-1(52.1±1.96微摩尔/千克·小时-1)。基于生理学的药代动力学模型未能模拟雌性大鼠在2000 - 5000 ppm时HCFC - 123摄取的减少。基于生理学的药代动力学模型还利用在气体摄取模拟研究中获得的体内代谢速率常数预测了HCFC - 123的主要尿代谢产物三氟乙酸的产生和排泄。二烯丙基硫醚是细胞色素P450 2E1的一种选择性、基于机制的抑制剂,它抑制了HCFC - 123的代谢,这表现为在二烯丙基硫醚处理的大鼠中HCFC - 123摄取减少以及三氟乙酸的尿排泄降低。

相似文献

1
Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).2,2-二氯-1,1,1-三氟乙烷(HCFC-123)的气体摄取药代动力学
Drug Metab Dispos. 1994 Jul-Aug;22(4):511-7.
2
Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).1,1 - 二氯 - 1 - 氟乙烷(HCFC - 141b)的气体摄取药代动力学及生物转化
Drug Metab Dispos. 1993 Jul-Aug;21(4):634-9.
3
Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.2-氯-1,1,1,2-四氟乙烷(HCFC-124)在大鼠、小鼠和仓鼠体内的气体摄取药代动力学及代谢情况
Drug Metab Dispos. 1995 Aug;23(8):875-80.
4
The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.细胞色素P450 2E1在大鼠和小鼠中对1,2 - 二氯 - 1,1,2 - 三氟乙烷物种依赖性生物转化中的作用。
Toxicol Appl Pharmacol. 1995 Dec;135(2):200-7. doi: 10.1006/taap.1995.1224.
5
Metabolism of 1,2-dichloro-1-fluoroethane and 1-fluoro-1,2,2-trichloroethane: electronic factors govern the regioselectivity of cytochrome P450-dependent oxidation.1,2 - 二氯 - 1 - 氟乙烷和1 - 氟 - 1,2,2 - 三氯乙烷的代谢:电子因素决定细胞色素P450依赖性氧化的区域选择性。
Chem Res Toxicol. 1996 Jan-Feb;9(1):50-7. doi: 10.1021/tx950086n.
6
Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat.
Toxicol Appl Pharmacol. 1994 Nov;129(1):103-13. doi: 10.1006/taap.1994.1233.
7
Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.大鼠和人肝微粒体对氯氟烃替代物1,1-二氯-2,2,2-三氟乙烷的代谢:细胞色素P450 2E1的作用
Chem Res Toxicol. 1994 Mar-Apr;7(2):170-6. doi: 10.1021/tx00038a009.
8
Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.苯巴比妥和吡啶诱导的大鼠肝微粒体对1,1-二氯-2,2,2-三氟乙烷(HCFC-123)进行还原代谢过程中细胞色素P450的失活。
Toxicol Appl Pharmacol. 1997 Apr;143(2):420-8. doi: 10.1006/taap.1996.8064.
9
Physiologically based pharmacokinetic analysis of the concentration-dependent metabolism of halothane.
Xenobiotica. 1997 Jan;27(1):87-99. doi: 10.1080/004982597240785.
10
Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats.
Xenobiotica. 1994 Sep;24(9):881-92. doi: 10.3109/00498259409043287.

引用本文的文献

1
Toxicology of chlorofluorocarbon replacements.氯氟烃替代品的毒理学
Environ Health Perspect. 1996 Mar;104 Suppl 1(Suppl 1):75-83. doi: 10.1289/ehp.96104s175.
2
Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes.设计更安全的化学品:预测卤代烷烃的代谢速率。
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11076-80. doi: 10.1073/pnas.92.24.11076.